Ram Aiyar, Ph.D., MBA, is the Chief Executive Officer and President of Korro Bio, and sits on the Board of Directors. Ram brings nearly two decades of diverse experience in biotech and pharma, working across all stages of development from launch to clinical to commercialization. He has a long history of launching and building biotech … Read more
Loïc Vincent, Ph.D., Chief Scientific Officer at Korro Bio, brings over 20 years of experience in drug discovery & translational research across academia, biotech and the pharmaceutical industry, with deep expertise in oncology and immunology-related disorders. Throughout his career, Dr. Vincent led teams that advanced more than 20 drugs into clinical development based on various … Read more
Todd Chappell, Chief Operating Officer at Korro Bio, brings twenty years of product development and product strategy experience. He previously served as senior vice president of strategy and portfolio planning at Korro Bio. Todd is a veteran industry executive who has led several early-stage therapeutic programs from discovery stage through to clinical trials. Most recently, he … Read more
Jeff Cerio, Pharm D., J.D. Senior Vice President General Counsel at Korro Bio, most recently General Counsel and Corporate Secretary at Atomwise, a technology-enabled pharmaceutical company leveraging the power of AI to revolutionize small molecule drug discovery, from October 2021 to August 2024. Jeff previously served as General Counsel at Triplet Therapeutics, Inc. from late … Read more
Stephanie Engels, Chief People Office at Korro Bio, bringing over 20 years of HR leadership experience in the life science and healthcare sectors. Prior to joining Korro, Ms. Engels served as Vice President, Head of HR Business Partnerships and Corporate Functions at Moderna, which included driving the organizational design and scaling of corporate functions pre- … Read more
Gaozhong Zhu, Ph.D., Senior Vice President of Chemistry, Manufacturing and Controls (CMC) & Technical Operations at Korro Bio, with more than 25 years of industrial experience in developing and implementing CMC strategies for various types of pharmaceuticals, with a proven track record of bringing new products from conception to commercialization. Before arriving at Korro, Dr. … Read more